Predicting complications after esophageal cancer treatment
Part of Cancer, Digestive system clinical trials.
This study looks at past medical records of people with esophageal cancer who received chemotherapy and radiation before surgery. Researchers want to find better ways to predict who might have complications after surgery, so they can improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed or suspected esophageal cancer tumor (not a rare type like sarcoma or neuroendocrine).
- You are 18 or older.
- Your cancer has not spread to distant organs (no stage IV).
- You have a good performance status (able to care for yourself, up and about at least half the day).
- You were treated with chemotherapy and radiation (nCRT) and then had surgery to remove your esophagus between 2015 and 2021 at one of the study centers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to manage complications after esophageal cancer surgery using a special algorithm. The goal is to improve recovery and care for patients who have this surgery.
This trial tests whether a personalized treatment plan, chosen using a lab-grown model of your tumor, works better than standard therapy for esophageal cancer that can be surgically removed. It aims to find the most effective drugs for you before surgery.
This research study uses medical records and imaging from patients with various esophageal conditions—from inflammation to cancer—to develop better diagnostic and prediction tools. Researchers want to understand what changes in the esophagus lead to cancer and how to catch it earlier.
This study looks back at past patients’ medical and pathology records from esophageal cancer surgeries. It may help improve how doctors understand which advanced tumors should be treated, by reviewing outcomes in specific tumor stages.
This trial compares two approaches for people with esophageal cancer that has shrunk or disappeared after initial chemotherapy combined with immunotherapy. It looks at whether adding targeted radiation (DCRT) or surgery is better. The goal is to find the most effective next step for eligible patients.
This trial uses a combination of imaging and clinical data to see if a computer model can predict how well your treatment will work. It aims to help doctors better understand your cancer risk and choose the best treatment plan for you.
Hear when a new The Aim of This Project is to Develop and Validate NTCP-models for Complications After nCRT (and Surgical Resection) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.